Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at NOK 919B, ahead of Eli Lilly (NOK 635.9B) and Merck & Co (NOK 634.3B). Figures as of 20 Nov 2026, 23:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonNOK 919B
- Median
- NOK 13.5B
- Combined market value
- NOK 36.45T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 919B | NOK 6.35T | NOK 2,638.92 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | NOK 635.9B | NOK 11.71T | NOK 13,143.48 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 634.3B | NOK 3.22T | NOK 1,304.68 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | NOK 610.6B | NOK 1.52T | NOK 267.34 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | NOK 596.7B | NOK 4.94T | NOK 2,792.40 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | NOK 470.2B | NOK 1.17T | NOK 573.70 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | NOK 432.5B | NOK 1.74T | NOK 1,004.95 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | NOK 139.9B | NOK 929.3B | NOK 8,982.99 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | NOK 139.5B | NOK 219.6B | NOK 191.53 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | NOK 117.1B | NOK 1.27T | NOK 5,024.95 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | NOK 92.4B | NOK 313.6B | NOK 771.86 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | NOK 46B | NOK 125.5B | NOK 251.14 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | NOK 36.2B | NOK 187.9B | NOK 1,403.22 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | NOK 31.4B | NOK 114.2B | NOK 589.41 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | NOK 31.1B | NOK 230.5B | NOK 5,412.39 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | NOK 29.5B | NOK 71.8B | NOK 206.06 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | NOK 23.2B | NOK 384B | NOK 667.85 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | NOK 16.9B | NOK 46B | NOK 550.48 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | NOK 10B | NOK 28.9B | NOK 148.79 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 9.4B | NOK 85.9B | NOK 3,698.80 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | NOK 9.2B | NOK 43.2B | NOK 259.34 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8.1B | NOK 57.1B | NOK 403.64 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | NOK 7.4B | NOK 67.9B | NOK 620.73 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | NOK 6.2B | NOK 66.4B | NOK 1,262.14 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | NOK 6B | NOK 93.4B | NOK 618.00 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | NOK 5.9B | NOK 302.5B | NOK 1,378.93 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5.1B | NOK 61.2B | NOK 937.92 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | NOK 4.9B | NOK 144.5B | NOK 741.81 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 44B | NOK 458.57 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | NOK 2.6B | NOK 56B | NOK 2,798.74 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.9B | NOK 76B | NOK 1,096.27 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | NOK 859M | NOK 69B | NOK 495.45 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | NOK 449M | NOK 77.3B | NOK 1,184.48 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | NOK 19.9M | NOK 46.5B | NOK 824.94 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | NOK 0 | NOK 86.6B | NOK 911.97 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | NOK 0 | NOK 81.9B | NOK 2,931.24 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7568 NOK). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (NOK 919B), Eli Lilly (NOK 635.9B) and Merck & Co (NOK 634.3B) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 23:22 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of NOK 36.45T as of 20 Nov 2026, 23:22 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.